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The effect ofsmeral pesticides, mammary ogens, and aniestrogens on 17-esradiol (E2),
16a- and2-hyroae activities, and 16ac-12-hydnestone (OHE1) ratios were ves ited in
MCF-7cels usinga adiometic assay. The mammarycaogens7,12-dimeylbez[a]antbane
(DMBA) and beno[a]pyrene (BaP), p , increased and decesd 16oa-12-OHE1 ratios at
some concentaons. The 16c-/2-OHE1 metabolite ratios for 10-5 M kepone, atrazine, p,f'-DDE,
o,p-DDE, o,p-DDT,andP-heahlorocydoheanewere 1.82 ± 0.060,0.71 ± 0.027,0.66 ± 0.030,
1.56 ± 0.089, 1.14 * 0.059 and 0.69 ± 0.052 (mean ± standard error), resp , and did not
showanyspecific trend. Theects ofaseres ofdirect and indirect a antiest on 16a-/2-
OHEI meabolite ratios were also in , and the results were compound speik Indole-3-
c nol, tam ifen, 4'-h y m , d 9-ci-retinoic acid de the ratio; the effc of
all trmsretinoic acid and 2,3,7,8-erxrabodibenzo-p-dioxin were concentration dependent; te
antiestrogen ICI 182,780 inceased the 16cc-12-OHEI metabolite rato. The results indicate that in
MCF-7 cells treated with pesicides, mamma rcinogens, and antiestrogens, there were both
increasedanddad 16a-12-OHEI metaboliteratiosforeachclassofchemicalsandtheassaydid
not predict mammarycarciogen. Key nwr es n, etr meabolism, m r car-
cinogens, 16a-l2OHEI ratios, pedes. Enven Heath Pepec 106:203-206 (1998). [Online
10March 1998]
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Epidemiology studies have identified several
risk factors for breast cancer in women;
these include early age at menarche, parity,
late age of menopause, and late age at first
pregnancy [reviewed in (1,2)]. All of these
conditions are associated with increased life-
time exposure to estrogens, which is an
important risk factor for this disease. The
precise role of 17,B-estradiol (E2) in devel-
opment of mammary cancer is unknown;
however, it is possible that this hormone or
its metabolites may influence more than
one step in the complex pathways that lead
to tumor formation (3-7).
It has been suggested that metabolism of
E2 into 2- and 16a-hydroxy metabolites,
such as 2-hydroxyestrone (2-OHE1) and
16a-OHE1, may play a role in mammary
carcinogenesis and that 2-OHEI and 16a-
OHEI may serve as biomarkers for this
process (8-10). Several in vivo and in vitro
studies have demonstrated that altered
metabolism ofE2 to give increased 16a- and
lower 2-hydroxy metabolites is correlated
with event(s) associated with tumor develop-
ment (8-15). Forexample, metabolism ofE2
to 16a-OHE1 in mammary terminal duct
lobular units, a target for mammary carcino-
gens, was higher in breast cancer patients
versus controls (13,14). These data were
consistent with laboratory animal studies in
mice with different susceptibilities for devel-
opment of mammary tumors (11), and it
was reported that the 16a-/2-OHE1
metabolite ratio was higher in breast cancer
patients versus controls (15).
It was also reported that the 16a-/2-
OHEI metabolite ratio in MCF-7 cells
treated with various compounds was a pre-
dictor of mammary carcinogens (8). For
example, 10-5 M concentrations ofvarious
pesticides and the mammary carcinogen
7,12-dimethylbenz[a]anthracene (DMBA)
increased this ratio, whereas the anticarcino-
gen indole-3-carbinol (I3C) and omega-3
fatty acids decreased the ratio in MCF-7
cells (8). These results were surprising for
two reasons. 13C induced CYPlAl at con-
centrations greater than 10-4 M (16-18);
therefore, it was surprising that CYPlAl-
dependent E2 2-hydroxylase activity was
induced by 10-5 M 13C. Also, most of the
organochlorine compounds used in the
prior study enhance CYP2B gene expres-
sion, and this response is not usually
induced in cancer cell lines (19). Results of
initial studies on induction ofE2 2-hydrox-
ylase activity in MCF-7 cells by pesticides,
mammary carcinogens, and anticarcinogens
gave results (20) that were both similar and
in contrast to those previously reported (8).
For example, 10-5 M 13C and DMBA,
respectively, increased and decreased 2-
hydroxylation of E2 using the radiometric
assay as previously reported; however, the
mammary carcinogen benzo[a]pyrene (BaP)
increased and the antiestrogens ICI 164,384
and 182,780 decreased E2 2-hydroxylase
activity (20). It is also possible thatvariability
between studies may also be related to the
instability of this cell line (21,22). In this
study, low passage MCF-7 cells were used
and monitored for both their estrogen and
aryl hydrocarbon responsiveness. This study
reports the effects of pesticides, mammary
carcinogens, and antiestrogens on E2 16a-
hydroxylase activity and 16a-/2-OHE1
metabolite ratios in MCF-7 cells. After treat-
ment ofMCF-7 cells with 10-5 M concen-
trations ofthe test compounds, the 16a-/2-
OHE1 metabolite ratios in MCF-7 cells did
notpredict mammarycarcinogens.
Materials and Methods
Chemicals. [16a-3H]E2 was custom synthe-
sized by NewEngland Nuclear (Boston, MA)
with specific activity of 1.00 mCi/ml and a
concentration of27.9 pmol/ml, andwas certi-
fied 99% pure by thin-layer chromatography
(TLC) and HPLC. [2-3H]E2 was purchased
from New England Nuclear with a specific
activity of 1.00 mCi/ml and a concentration
of 45.45 pmol/ml. ICI 182,780 [7a-(9-
(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-
estra-1,3,5(10)triene-3,17-1-diol] was
furnished by Alan Wakeling (Zeneca
Pharmaceuticals, Macclesfield, UK).
Minimum essential medium (MEM) was
purchased from Gibco RBL (Grand Island,
NY) and fetal bovine serum was purchased
from Intergen Company (Purchase, NY).
Tamoxifen, 4-hydroxytamoxifen, linoleic
acid, all-trans-retinoic acid, and 9-cis-retinoic
acid were obtained from Sigma (St. Louis,
MO). 2,3,7,8-Tetrachlorodibenzo-p-dioxin
(TCDD) was greater than 98% pure and syn-
thesized in this laboratory. Kepone, 1,1-
dichloro-2-(p-chlorophenyl) -2-(o-
chlorophenyl)ethylene (o,p'-DDE), 1,1,1-
trichloro-2-(p-chlorophenyl)-2-(o-
chlorophenyl)ethane (o,p'-DDT), and 1,1-
dichloro-2,2-bis(p-chlorophenyl)ethylene
(p,p'-DDE) were greater than 99% pure and
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Figure 1. Induction of 17,B-estradiol (E2) 2- and 16a-hydroxylase activity in
MCF-7 cells by TCDD. Cells were treated with different concentrations of
TCDD or DMSO (control) for 48 hr and the metabolism of E2 to 2- and 16a-
hydroxymetabolites were determined as described in Materials and Methods
using the radiometric assay with 2-[31HE2 or 16a-[3H1E2 as substrates. The
results are presented as mean ± standard error for four replicate determina-
tions and are expressed as percent of control values.
*Significantly increased above control values (p<0.05).
`Significantly decreased below control values (p<0.05).
(Research Triangle Park, NC). BaP and
DMBA were purchased from Aldrich
Chemical Co. (Milwaukee, WI) and were
greater than 98% pure. Atrazine (97%) was
purchased from ChemService (West Chester,
PA) and 13C was obtained from Aldrich
Chemical Company. All other chemicals and
biochemicals were thehighest purityavailable
from commercial sources.
Radiometric E2 16a-hydroxylse activity
in MCF-7 cells. MCF-7 human breast can-
cer cells were obtained from the American
Type Culture Collection (Rockville, MD).
Cells were grown to 85% confluency in T-
150 flasks in minimal essential media + 10%
fetal bovine serum and seeded into T-25
flasks (Corning, Corning, NY) at adensityof
1.0 x 106 cells/plate. Afterallowing24 hr for
attachment, cells were maintained with fresh
serum-free media for24 hr. Cells were prein-
cubated for 48 hr with test compounds in 5
il DMSO (0.1%) or 5 pl DMSO alone
(control) in media containing 2.5% dextran-
coated charcoal-stripped fetal bovine serum.
Cells were treated for 48 hr with equal doses
ofthe same test compounds and [16a-3H]E2
at a final activity of 100 nCi/ml in fresh
serum-stripped media. Aliquots (5.0 ml) of
freshly prepared activated charcoal solution
containing 0.25% activated charcoal and
0.0025% dextran in 0.1 M Tris-HCI (pH
8.0) buffer were centrifuged for 10 min at
1500 x g(4°C) in borosiicate test tubes and
the supernatant was removed. Culture media
(5.0 ml) obtained after incubation with test
compounds + radiolabeled E2 were added to
charcoal pellets, incubated for 30 min (4°C)
with gentle vortexing, and then centrifuged
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Figure 2. Induction of 17)-estradiol (E2) 2- and 16ax-hydroxylase activity in MCF-7
cells by control (DMSO), indole-3-carbinol (13C), pesticides, and mammary car-
cinogens. Abbreviations: DMBA, 7,12-dimethylbenz[alanthracene; BaP,
benzo[alpyrene. Cells were treated with different concentrations ofthe test com-
pounds for 48 hr, and the metabolism of E2 to 2- and 16a-hydroxymetabolites
were determined as described in Materials and Methods using the radiometric
assay with 2-[3H]E2 or 16a-[3H]E2 as substrates. The results are presented as
mean ± standard error for three replicate determinations and are expressed as
percent of control values. The induction of ethoxyresorufin-O-deethylase activity
in controls and in cells treated with 10-6 and 10-5 M BaP was 3.0 ± 1.8, 188 ± 36,
and 18.7 ± 2.5 pmol/min/mg, respectively.
*Significantly increased above control values(p<0.05).
**Significantly decreased below control values (p<0.05).
for 15 min at 1500 x g (40C). Supernatant
was analyzed for radioactivity in five aliquots
(0.99 ml) by scintillation counting. [16ac-
3H]E2 background radioactivity was caused
by the slow spontaneous loss oftritium. The
background levels were determined in paral-
lel experiments by ethanol-fixing MCF-7
cells prior to the addition ofDMSO + [16ct-
3H]E2 for each experiment and were sub-
tracted from the total radioactivity of each
treatment to determine the net E2 hydroxy-
lase activity (20). The background was
0.65% ofthe total radioactivity and did not
increase significantly during the course of
these studies. The average net metabolism of
control cells was 2% ofthe total [16a-3H]E2
substrate added. For each treatment, four
plates of cells were processed at the same
time; results are presented as mean ± stan-
dard error (SE) and as a percent ofmetabo-
lism or metabolite ratios in controls (DMSO
treatment). The value for each plate is the
average ofthe quantitation offive aliquots of
its charcoal-washed media. Each experiment
was repeated at least once on a separate occa-
sion. The standard error for the 16a-/2-
OHEI ratio was determined by propagating
the error of the two individual measure-
ments, and treatments were compared
against controls usingStudent's t-test.
Radiometric E2 2-hydroxylase activity
in MCF-7 cells. To determine the E2-2-
hydroxylase activity, a protocol identical to
the one above was utilized, using [2-3H]E2
as the radiolabeled substrate, as previously
described (20). 166a-Hydroxylase activity
and 2-hydroxylase activity were analyzed
with analysis of variance (ANOVA) and
Scheffe's test.
Results
The effects of various chemicals on E2 2-
hydroxylase activity (radiometric assay) in
MCF-7 cells were recentlyreported (20), and
this studyhas expanded the numberofchem-
icals to determine their effects on E2 2- and
160c-hydroxylase activities and their 160c-/2-
OHE1 metabolite ratios. Figure 1 illustrates
the concentration-dependent induction ofE2
2-hydroxylase activity by TCDD, and this
paralleled previous studies on induction of
CYPlAI-dependent activity (23-26).
TCDD also induced E2 16a-hydroxylase
activity at concentrations from 10-8 to 10-1o
M. 16at-/2-OHE1 metabolite ratios were
concentration dependent and varied from
1.02 to 0.57. Treatment ofMCF-7 cellswith
the mammary carcinogen DMBA (10-7-10-5
M) decreased both E2 2- and 16a-hydroxy-
lase activities; however, the 16a-/2-OHE1
metabolite ratios were significantly greater
than 1.0 at the 10-7 and 10-5 M concentra-
tions (Fig. 2). Induction ofCYPlAl-depen-
dent E2 2-hydroylase activity was observed
after treatment ofMCF-7 cells with 10-5 M
BaP. However, the 16cX-/2-OHE1 ratios
were dependent on the concentration ofBaP
and varied from 0.08 to 1.17; these results
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Figure 3. Induction of 171-estradiol (E2) 2- and 16a-hydroxylase activity in MCF-
7 cells by organochlorine pesticides, linoleic acid, and antiestrogens. f-HCH, ,B-
hexachlorocyclohexane. Cells were treated with DMSO (control) or different
concentrations of the test compounds for 48 hr, and the metabolism of E2 to 2-
and 16a-hydroxymetabolites were determined as described in Materials and
Methods using the radiometric assay with 2-[3H1E2 and 16a-[31H-E2 as sub-
strates. The results are presented as mean ± standard error forthree replicate
determinations and are expressed as percent of control values.
*Significantly increased above control values(p<0.05).
**Significantly decreased below control values(p<0.05).
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Figure 4. Induction of 17p-estradiol (E2) 2- and 16x-hydroxylase activity in
MCF-7 cells by retinoids and ICI 182,780. Cells were treated with DMSO (con-
trol) or with different concentrations ofthe test compounds for 48 hr, and the
metabolism of E2 to 2- and 16ot-hydroxymetabolites were determined as
described in Materials and Methods, using the radiometric assay with 2-
[3H]E2 and 16ct-[3H1E2 as substrates. The results are presented as mean ±
standard error for three replicate determinations and are expressed as per-
cent of control values.
*Significantly increased above control values (p<0.05).
**Significantly decreased below control values (p<0.05).
differed markedly from the corresponding
ratios obtained for DMBA.
The remaining results summarized in
Figures 2 to 4 were obtaining using com-
pounds previously investigated by Bradlow
andco-workers (8) aswell asseveraldrugs that
exhibit antiestrogenic and/or antitumorigenic
activity. The results obtained forthepesticides
were highlyvariable; 16cx-/2-OHEl ratios for
10-5 M kepone, atrazine, p,p'-DDE, o,p'-
DDE, o,p'-DDT, and 0-hexachlorocyclo-
hexane were 1.82 ± 0.060, 0.71 ± 0.027, 0.66
± 0.030, 1.56 ± 0.089, 1.14 ± 0.059, and0.69
± 0.052, respectively. Metabolite ratios for
13C were greater than 1.0 as previously
reported (20), whereas the value for linoleic
acid was 0.74 ± 0.039. The 16ax-/2-OHE1
ratios for the antiestrogens tamoxifen (10-5
_10-8 M) and 4-hydroxytamoxifen were
greaterthan 1.0 (Fig. 3),whereas ratios forthe
10-8, 10-7, and 104 M concentrations ofthe
antiestrogen ICI 182,780 were 1.59 ± 0.30,
1.74 ± 0.09, and 2.19 ± 0.21, respectively
(Fig. 4). Compared to control cells, the effects
ofall-transand9-cis-retinoic acid on E22- and
16a-hydroxylase activities and their ratios
wereminimal (Fig. 4).
Discussion
Bradlow and co-workers (8) previously sug-
gested that the effect ofvarious pesticides on
the 16a-/2-OHE1 metabolite ratios in
MCF-7 cells was a biologic marker ofbreast
cancer risk. These studies were carried outby
treating MCF-7 cells for 48 hr with [3H]E2
substrates and 10-5 M concentrations ofthe
various compounds. Previous reports have
demonstrated that E2 2-hydroxylase activity
is a CYPlAI-dependent response in in vitro
cancercell lines (23-26), whereas CYP1A2 is
the major catalyst for this enzyme activity in
vivo (27-29). CYPlAI and CYP1A2 are
important phase I drug-metabolizing
enzymes, which are induced byvarious xeno-
biotics that bind the aryl hydrocarbon recep-
tor. Our initial interest in reexamining this
assay and its predictive utility stemmed from
two observations: 1) itwas reported that 10-5
M I3C induced E2 2-hydroxylase activity
(8), whereas induction ofCYP1A1 by 13C in
MCF-7 cells requires concentrations greater
than 100 pM (16,17); and 2) most of the
organochlorine pesticides used in the study
resemble phenobarbital as inducers of
CYP2B-dependent activity, and this induc-
tion response is not observed in most cancer
cell lines. Using the radiometric assay for E2
2-hydroxylase activity, the reported up regu-
lation ofthis response by13C was confirmed
(20) and was also observed in the present
study (Fig. 2). 13C increased E2 2-hydroxy-
lase activity after treatment for 2 hr (20);
however, the amount of metabolite formed
was low. BaP also induced this response (20);
this contrasted with the marked decrease of
E2 2-hydroxylase activity in MCF-7 cells
treated with DMBA (8,20). Previous studies
on induction of E2 2-hydroxylase activity in
this laboratory (20) showed some differences
and similarities with data reported by
Bradlow and co-workers (8). This study has
reexamined induction of both E2 16a- and
2-hydroxylase activities and metabolite ratios
after treatment of MCF-7 cells with diverse
pesticides, mammary carcinogens, and anti-
carcinogens in MCF-7 cells.
TCDD was used as a positive control
because it induces CYPlAl-dependent
activities (including E2 2-hydroxylase) in
MCF-7 cells and other aryl hydrocarbon
responsive tissues (18,23-26,30,31). This
was also paralleled by induction of E2 2-
hydroxylase activity (Fig. 1). 13C (10- M)
also induced E2 2-hydroxylase activity (Fig.
2) as previously reported (8,20), even
though induction of CYPlAI mRNA or
immunoreactive protein by this compound
is observed at concentrations greater than
10-4 M in MCF-7 cells (16,17). This
induction response may be related to eleva-
tion of other CYP isozymes, and this
requires further investigation.
The report which suggested that the
16a-/2-OHEI metabolite ratios in MCF-7
cells could be used as a predictive biologic
marker for mammary carcinogens showed
that the ratio was highest (>5) for atrazine,
p,p'-DDE, o,p'-DDT, and p,p'-DDE and
was also increased for the mammary car-
cinogen DMBA (8). In this study, elevated
metabolite ratios were also observed for 10-5
M o,p'-DDE (1.56 ± 0.09), kepone (1.81 ±
0.06), and DMBA (2.47 ± 0.21), whereas
these ratios were not significantly greater
than 1 for the remaining compounds. The
most striking difference in 16c-/2-OHE1
metabolite ratios was observed for the
mammary carcinogens DMBA and BaP
(Fig. 2). In cells treated with DMBA,
metabolites ratios were higher than 1 for all
concentrations, whereas the ratios for 10-6
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and 10-5 M BaP were 1.17 ± 0.08 and 0.08
± 0.009, respectively. The 16a-/2-OHEI
ratios obtained for 10-5 M BaP and DMBA
were the lowest and highest, respectively,
for all compounds used in this study. The
ratio was also investigated for a series of
antiestrogens that act through the estrogen
receptor (ER) (tamoxifen, 4'-hydroxyta-
moxifen, and ICI 182,780) or via crosstalk
with the ER signaling pathway (TCDD,
trans-retinoic acid, and 9-cis-retinoic acid).
The 16a-/2-OHE1 ratios for most ofthese
compounds were <1.0; however, values
from 1.59 to 2.19 were observed for the
antiestrogen ICI 182,780 (10-8-_10-6 M),
which is being developed for treatment for
mammary cancer (32).
Thus, results from these studies show
that mammary carcinogens and antiestro-
gens both increase and decrease 16a-/2-
OHEI metabolite ratios in MCF-7 cells,
and the ratio was not a biologic marker of
breast cancer risk. The reasons for differ-
ences between this study and the prior
report (8) are unknown; however, MCF-7
cell lines can be highly variable with respect
to wild-type and variant ER expression and
E2 responsiveness (21,22), as well as
inducibility ofCYPlAI-dependent activities
(23). Retention ofCYPlAI inducibility was
periodically monitored in this study by con-
firming induction of CYPlAl-dependent
E2 2-hydroxylase (Fig. 1) and ethoxyre-
sorufin O-deethylase activities (data not
shown) by TCDD. A recent study by
Telang et al. (10) summarized the effects of
DMBAand BaP on 16a-/2-OHE1 metabo-
lite ratios in explant cultures of human
mammary terminal duct lobular units and
human mammary epithelial 184-B5 cells.
They reported that both DMBA and BaP
increased 16a- and decreased 2-hydroxyla-
tion of E2; this was accompanied by
increased 16a0-/2-OHE1 metabolite ratios.
Thus, in contrast to MCF-7 cells, BaP did
not induce CYPlAI-dependent E2 2-
hydroxylase activity in these in vitrosystems.
It is possible that assays using explant cell
cultures maybe more useful than breast can-
cer cell lines for predicting some classes of
mammary carcinogens. However, it is clear
from results of this study that a diverse
group ofcompounds should be used to test
the predictive utility ofan in vitrobioassay.
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